Zhao Bingxiang, General Manager of china meheco group, stated during the keynote speech at the 2024 China Pharmaceutical Industry Development Conference and the Shanghai International Biomedical Industry Week Forum on November 16, that currently, a new round of technology revolution and industrial transformation is deeply advancing, with continuous breakthroughs in frontier technologies and successive disruptive innovations, providing historic opportunities for accelerating the development of new productive forces in the pharmaceutical industry. Efforts should be focused on cultivating new productive forces in the pharmaceutical industry and promoting high-quality development by concentrating efforts on four aspects: industrial safety, technological innovation, structural optimization, and cooperation and openness.